날짜

시간

주제

강사

09.02

09:00~09:15

Definition and pathogenesis of degenerative myopia

김상국(충북대)

09.02

09:15~09:30

Fundus changes & retinal detachment in degenerative myopia

김시동(대구가톨릭대)

09.02

09:30~09:45

Angiographic findings in degenerative myopia

이원기(대구가톨릭대)

09.02

09:45~10:00

Myopic CNV: management update

함돈일(성균관대)

09.02

10:00~10:15

Refractive surgery and retinal detachment in degenerative myopia

손준홍(한길안과)

09.02

10:15~10:30

non-rhegmatogenous macular detachment in degenerative myopia; vitreous changes & Management

정흠(서울대)

09.02

10:30~10:45

Myopic macular hole with and without retinal detachment; Treatment options

엄부섭(부산대)

09.02

10:45~11:00

Discussion

.

09.02

11:15~11:30

ILM removal: rationale, indications, and toxicity concerns

이정희(이화여대)

09.02

11:30~11:45

How to improve visualization of invisible structures during vitreous surgery?

박규형(서울대)

09.02

11:45~12:00

1. Predictors of BPH progression

김형찬(건국대)

09.02

12:00~12:15

Does SST result influence on the management of submacular hemorrhage?

김광수(계명대)

09.02

12:15~12:30

Sutureless vitrectomy : Expanding the indications of 25G vitrectomy

권오웅(연세대)

09.02

12:30~12:45

Sutureless vitrectomy : 23G vitrectomy: the early experiences

김종우(건양대)

09.02

12:45~13:00

Discussion

.

09.02

14:00~14:15

Pharmacokinetics of periocular, intravitreal & sustained release steroid

이지은(부산대)

09.02

14:15~14:30

The early experiences with anti-VEGF agent (Bevacizumab) : Pharmacology

허걸(고려대)

09.02

14:30~14:45

The early experiences with anti-VEGF agent (Bevacizumab) : preparations of drugs

유승영(경희대)

09.02

14:45~15:00

The early experiences with anti-VEGF agent (Bevacizumab) : for neovascular AMD

이성철(연세대)

09.02

15:00~15:15

The early experiences with anti-VEGF agent (Bevacizumab) : or diabetic retinopathy

김시열(경북대)

09.02

15:15~15:30

Discussion

.

09.02

15:45~16:45

Mystery Macula - Cases & Panel Discussion

김하경 (한림대),최광주(조선대),윤희성(성모안과),김